Literature DB >> 8868285

Effect of induced hypertension with angiotensin II infusion on biodistribution of 111in-labeled monoclonal antibody.

S Kinuya1, K Yokoyama, S Konishi, N Tonami, K Hisada.   

Abstract

We investigated whether induced hypertension could enhance tumor uptake of monoclonal antibody. 111In-DTPA-A7 (IgG1 against 40kD tumor associated glycoprotein) was injected into colon carcinoma xenografted mice which were subcutaneously implanted with micro-osmotic pump containing angiotensin II (AT-II). Biodistribution was observed in groups of mice infused with AT-II at rate of 0.5 micrograms/kg/min (L) or 1 microgram/kg/min (H) and compared with a group of mice infused with saline (S). Tumor uptake of 111In-A7 in L and H was 1.32 and 1.57 times greater than S at 48 h after intravenous injection of A7. Normal organ uptakes also tended to be increased by AT-II infusion. Further study is needed to get optimum effect of hypertensive treatment on biodistribution of radiolabeled MoAb.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8868285     DOI: 10.1016/0969-8051(95)02040-3

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  3 in total

1.  A novel immunoscintigraphy technique using metabolizable linker with angiotensin II treatment.

Authors:  Y Nakamoto; H Sakahara; T Saga; N Sato; S Zhao; Y Arano; Y Fujioka; H Saji; J Konishi
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

Review 2.  Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.

Authors:  Mikhail O Durymanov; Andrey A Rosenkranz; Alexander S Sobolev
Journal:  Theranostics       Date:  2015-06-08       Impact factor: 11.556

3.  Rhenium-186-mercaptoacetyltriglycine-labeled monoclonal antibody for radioimmunotherapy: in vitro assessment, in vivo kinetics and dosimetry in tumor-bearing nude mice.

Authors:  S Kinuya; K Yokoyama; H Tega; T Hiramatsu; S Konishi; W Yamamoto; N Shuke; T Aburano; N Watanabe; T Takayama; T Michigishi; N Tonami
Journal:  Jpn J Cancer Res       Date:  1998-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.